The 5′ noncoding regions of BRCA1 and BRCA2 in early onset or familial BC patients with no known BRCA1 or BRCA2 germline pathogenic variant were sequenced at nine different sites as part of an approved ENIGMA (https://enigmaconsortium.org/) project. Here, BRCA2 is linked to breast cancer.